Effect of syzygium and cinchona ointments on pain intensity
Not Applicable
Recruiting
- Conditions
- Coronary artery disease.Atherosclerotic heart disease of native coronary artery
- Registration Number
- IRCT20160110025929N21
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
BMI Between 25-19
Patient alertness and ability to analyze pain
The absence of uncontrolled coagulation disorders
Exclusion Criteria
Having allergies to herbal medicines
Infection and inflammation in the skin of the target area
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain intensity. Timepoint: Before and after intervention. Method of measurement: Visual analoge scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Syzygium and Cinchona ointments alleviate enoxaparin-induced injection pain in acute coronary syndrome patients?
How do Syzygium and Cinchona ointments compare to standard-of-care analgesics in managing enoxaparin injection pain for coronary artery disease?
Which biomarkers could predict patient response to Syzygium or Cinchona ointments in reducing enoxaparin injection pain in atherosclerotic heart disease?
What are the potential adverse events associated with Syzygium and Cinchona ointments in acute coronary syndrome treatment protocols?
Are there related compounds or combination therapies that enhance the efficacy of Syzygium or Cinchona ointments against enoxaparin injection pain in coronary artery disease?